250 words 25 Text: 4593 words 26 Abstract 32 Background. Enterotoxigenic Escherichia coli (ETEC) cause diarrheal illness in infants in 33 the developing world and travelers to endemic countries including military personnel. ETEC 34 infection of the host involves colonization of the small intestinal epithelium and toxin 35 secretion leading to watery diarrhea. There is currently no vaccine licensed to prevent ETEC. 36 CFA/I is one of the most common colonization factor antigens (CFAs). The CFA/I adhesin 37 subunit, CfaE, is required for ETEC adhesion to host intestinal cells. Human antibodies 38 against CfaE have potential to block colonization of ETEC and serve as an 39 immunoprophylactic against ETEC-related diarrhea.
To assess HuMab recognition of CfaE expressed by live bacteria, H10407 strain was grown 141 in an iron starvation condition to induce CfaE protein expression (20) . The bacteria was then 142 incubated with each of the lead ten HuMabs, followed by fluorescence-conjugated secondary 143 antibody and FACS analysis. All HuMabs showed strong binding activity to the H10407 144 strains. The binding activities were comparable among all ten antibodies (Figure 1 147 To determine whether the lead HuMabs were capable of inhibiting bacterial adhesion, a cell 148 adhesion assay with Caco-2 cells (a human intestinal epithelial cell line) was performed. An 149 example of concentration-dependent inhibition curve is reported in Figure 2 , Panel B. The 150 minimal inhibitory concentrations needed to prevent 50% (IC 50 ) of bacterial adhesion were 151 reported as antibody potency. All ten HuMabs showed strong potency to block bacteria 152 adhesion at IC 50 concentrations between 0.3 to 1.3 ug/mL. HuMab 68-51, 68-61 and 68-97 158 To define the antibody-binding epitope, putative antibody-antigen interaction models were 159 established based on a previously resolved CfaE structure (PDB ID 2Hb0) and the lead 160 HuMab antibody sequences using an antibody modeling program, BioLuminate 161 (Schrodinger). This software suite develops models of antibody structures from their 162 sequences, followed by computational docking to identify high-confidence antibody-antigen 163 complex models. Based on these models, the software identified potential residues critical 164 for binding interaction. The effect of these residues on the binding activity of the HuMAbs 165 was analyzed by experimental alanine scanning followed by ELISA. ELISA results indicated 166 that mutating five of the predicted residues to alanine affected HuMAb binding (Figure 3 ).
Anti-CfaE HuMabs prevent ETEC adherence to intestinal cells at low concentrations

Epitope Mapping of lead anti-CfaE HuMabs
167
The R67A . N127A mutation eliminated binding 172 activity of HuMAb 68-61 and reduced binding of HuMAbs 68-48 and 68-6 (Panel F).
173
Summary of the residues discovered to affect binding are shown in Figure 3 Isotype switch of anti-CfaE HuMabs to sIgA. Seven IgG1 HuMab (68-51, 68-61, 68-97, 68-179 90, 67-102, 68-48, and 840-53) found to have the lowest IC 50 values in Caco-2 cell adhesion 180 assays were selected as the leads for further characterization in immunoglobulin class 181 switching. Antibody variable regions were cloned into an expression vector with IgA 182 constant region to generate monomeric IgA. Monomeric IgA antibodies were also co-183 expressed with J chain with or without secretory component to produce dimeric IgA (dIgA) 184 and secretory IgA (sIgA) respectively. Antibodies with various isotypes were tested for their 185 functionality in Caco-2 cell adhesion assays ( Figure 4 ). In general, all the antibodies retained 10 a dimeric IgA1 or IgA2 did not affect functional activity of HuMAb 67-102, but switching 193 from dimeric to secretory IgA1 or IgA2 did significantly increase in vitro activity of 67-102. 194 Due to low expression yields, we were not able to generate sufficient 68-51 sIgA1 or sIgA2 195 for in vitro testing. 
Anti-CfaE HuMabs prevent ETEC colonization in the small intestine of a mouse model 198
HuMAbs 68-61, 68-97, and 840-53 were found to have the lowest IC 50 values as IgG1, 199 sIgA1, and sIgA2 and were selected as the leads for further characterization in animal studies 200 ( Figure 5 ). Groups of 5 DBA2 mice were given a mixture of bacteria and anti-CfaE HuMAbs 201 (10 mg/Kg) by oral gavage. 24 hours after challenge, the mice were euthanized and the CFU 202 in the small intestine were counted as described in the methods. The efficacy of the anti-203 CfaE HuMAbs was assessed by determining whether the HuMAbs could prevent adhesion of 204 bacteria to the small intestine compared to an irrelevant isotype control. In the 68-61 group, 205 treatment with IgG1 decreased CFU by100 fold compared to the irrelevant antibody control.
206
A similar result was observed for 68-61 sIgA2 and sIgA1 compared to the irrelevant control.
207
The reduction of CFU observed in the 68-97 group compared to the irrelevant control was 208 similar across the different subclasses. In the 840-53 group, mice treated with IgG1 showed 209 less bacteria compared to sIgA2, while sIgA1 also showed a decrease in bacteria relative to 210 sIgA2, though these differences were not significant. formed by three arginine residues, Arg67, Arg181 and Arg182, and a cluster of surrounding 231 residues, which are all highly conserved among the Class-5 fimbriae adhesins. Mutations of 232 the arginine residues result in a complete loss of binding activity of ETEC to host cells (18).
233
Putative antibody-antigen interaction models were established utilizing the sequences of 234 CfaE (PDB ID 2HB0) and the anti-CfaE HuMAbs with the aid of an antibody modeling 235 program (BioLuminate, Schrödinger). A set of residues predicted to be important for the 236 binding interaction based on the top-ranked model were selected for experimental alanine 237 scanning, and were confirmed to be energetically critical using ELISA. HuMabs 68-51 and 12 68-97, the antibodies with the highest in vitro functional activity, were found to bind directly 239 to Arg67 (part of the putative receptor binding domain). Four more residues, Arg145, Thr91, 240 Tyr183, and Asn127, located in the proximity of the receptor binding domain, were 241 recognized by other nine lead anti-CfaE HuMabs (Figure 3 ). Together, our data suggest that were combined in a 1:10 ratio and allowed to shake at 300 rpm for one hour at room 387 temperature. After incubation, 0.2 mL of antibody/bacteria mixture was added to each well 388 containing Caco-2 cells. The cells were then incubated statically for 3 hours at 37°C. Cells 389 were then washed four times with 1 mL PBS to remove non-adherent ETEC cells.
390
Afterwards, Caco-2 cells were dislodged with 0.2 mL 0.25% trypsin. Cells were collected via 391 gentle centrifugation and resuspended in 1mL PBS. Dilutions were plated on CFA agar plates 392 and colonies counted the next day. IC 50 was defined as concentration of HuMAb needed to 393 inhibit 50% of ETEC adhesion to the Caco-2 cells, compared to an irrelevant isotype 394 antibody. 
